362 related articles for article (PubMed ID: 28322156)
1. Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy.
Mikulandra M; Pavelic J; Glavan TM
Curr Med Chem; 2017; 24(19):2011-2032. PubMed ID: 28322156
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
[TBL] [Abstract][Full Text] [Related]
3. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors: cost or benefit for cancer?
Matijevic T; Pavelic J
Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
[TBL] [Abstract][Full Text] [Related]
5. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
Makkouk A; Abdelnoor AM
Immunopharmacol Immunotoxicol; 2009; 31(3):331-8. PubMed ID: 19555209
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
8. Targeting pattern-recognition receptors to discover new small molecule immune modulators.
Zhu G; Xu Y; Cen X; Nandakumar KS; Liu S; Cheng K
Eur J Med Chem; 2018 Jan; 144():82-92. PubMed ID: 29268133
[TBL] [Abstract][Full Text] [Related]
9. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
Sun L; Liu W; Zhang LJ
J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors (TLRs) in aquatic animals: signaling pathways, expressions and immune responses.
Rauta PR; Samanta M; Dash HR; Nayak B; Das S
Immunol Lett; 2014; 158(1-2):14-24. PubMed ID: 24291116
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor agonists in cancer therapy.
Adams S
Immunotherapy; 2009 Nov; 1(6):949-64. PubMed ID: 20563267
[TBL] [Abstract][Full Text] [Related]
12. TLR based therapeutics.
Dunne A; Marshall NA; Mills KH
Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists.
Keshavarz A; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
IUBMB Life; 2021 Jan; 73(1):10-25. PubMed ID: 33217774
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors in inflammation of the central nervous system.
Kong Y; Le Y
Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor agonists: a patent review (2011 - 2013).
Hussein WM; Liu TY; Skwarczynski M; Toth I
Expert Opin Ther Pat; 2014 Apr; 24(4):453-70. PubMed ID: 24456079
[TBL] [Abstract][Full Text] [Related]
17. Recent patents in Toll-like receptor pathways and relevance to cancer.
Kimbro K; Parker S
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):189-95. PubMed ID: 19522696
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
19. [Toll-like receptors].
Essakalli M; Atouf O; Bennani N; Benseffaj N; Ouadghiri S; Brick C
Pathol Biol (Paris); 2009 Jul; 57(5):430-8. PubMed ID: 18513891
[TBL] [Abstract][Full Text] [Related]
20. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
